# Inflammatix

> Inflammatix is a molecular diagnostics company in Sunnyvale, California that reads the patient's own immune response to speed decisions in emergency and critical care. Its FDA-cleared TriVerity Test System measures a 29-mRNA host-response panel from whole blood on the benchtop Myrna instrument, returning three machine-learning-derived scores — bacterial infection likelihood, viral infection likelihood, and risk of severe illness within seven days — in about 30 minutes.

Generated: 2026-08-01
Method: generated (no /llms.txt is published by Inflammatix; probed 2026-08-01, HTTP 404 on inflammatix.com, www.inflammatix.com and support.inflammatix.com)
Source: API Evangelist enrichment pipeline, from apis.yml and the artifacts in https://github.com/api-evangelist/inflammatix

## Important scope note

Inflammatix publishes **no developer API** for its clinical products. There is no
patient, sample, order, result or instrument resource on any public surface. The
TriVerity page advertises that the Myrna instrument supports "multiple LIS
connectivity options" and remote notification, but no interface specification,
conformance statement or integration guide is published — whether that is HL7 v2,
ASTM or a proprietary interface is not disclosed.

The two APIs below are the WordPress REST content APIs the company serves from its
corporate site and its customer support portal. They are real, anonymously readable,
and useful for research — they are not clinical interfaces.

## APIs

- [Inflammatix Site Content API](https://inflammatix.com/): WordPress REST content API at https://inflammatix.com/wp-json/wp/v2 — posts, pages, media, taxonomies, site search, and the company's own `publication` custom post type holding its peer-reviewed clinical evidence library.
- [Inflammatix Support and Training Content API](https://support.inflammatix.com/): WordPress REST content API at https://support.inflammatix.com/wp-json/wp/v2 — support content plus the MemberPress Courses types (`mpcs-course`, `mpcs-lesson`, `mpcs-quiz`) backing the TriVerity/Myrna operator-training curriculum. Catalogue metadata is public; lesson bodies are behind the customer login.

## Specs

- [Site Content OpenAPI 3.1](openapi/inflammatix-content-openapi.yml): 20 operations, derived verbatim from https://inflammatix.com/wp-json/
- [Support Content OpenAPI 3.1](openapi/inflammatix-support-content-openapi.yml): 26 operations, derived verbatim from https://support.inflammatix.com/wp-json/
- [Site Content overlay](overlays/inflammatix-content-overlay.yaml)
- [Support Content overlay](overlays/inflammatix-support-content-overlay.yaml)

## Artifacts

- [Authentication](authentication/inflammatix-authentication.yml): WordPress Application Passwords over HTTP Basic; not required for any modelled operation
- [Conventions](conventions/inflammatix-conventions.yml): pagination, filtering, sparse fields, error envelope, caching, CORS; no idempotency, no rate-limit headers
- [Error catalog](errors/inflammatix-problem-types.yml): WordPress `{code, message, data}` envelope — not RFC 9457
- [Data model](data-model/inflammatix-data-model.yml): entity graph read from each site's own type and taxonomy registries
- [Lifecycle](lifecycle/inflammatix-lifecycle.yml): namespace-path versioning; no status page, no deprecation policy, no API changelog
- [Conformance](conformance/inflammatix-conformance.yml): ISO 13485:2016, FDA clearance, California device manufacturing licence; no SOC 2, no OAuth, no FHIR
- [Domain security](security/inflammatix-domain-security.yml): TLS 1.3 on both hosts, no HSTS, no DNSSEC, no CAA, SPF present, DMARC p=quarantine
- [Well-known probe](well-known/inflammatix-well-known.yml): every /.well-known/ path 404s on every host
- [MCP candidate](mcp/inflammatix-mcp.yml): no MCP server exists; a candidate tool list only
- [Agent skills](skills/_index.yml): three packaged skills grounded in real operationIds
- [Examples](examples/): live response payloads captured 2026-08-01

## Docs

- [TriVerity Test System](https://inflammatix.com/triverity/)
- [Clinical evidence and publications](https://inflammatix.com/evidence/)
- [Product pipeline](https://inflammatix.com/pipeline/)
- [Education: acute infection, sepsis, immune response, machine learning](https://inflammatix.com/education/)
- [About, certifications and licences](https://inflammatix.com/about-us/)
- [Patents](https://inflammatix.com/patents/)
- [Customer support portal](https://support.inflammatix.com/)
- [Newsroom](https://inflammatix.com/newsroom/news/)
- [Press releases](https://inflammatix.com/newsroom/press-releases/)
- [Contact](https://inflammatix.com/contact-inflammatix/)
- [Privacy and cookies statement](https://inflammatix.com/privacy-and-cookies-statement/)
- [Terms and conditions](https://inflammatix.com/terms-and-conditions/)

## What is NOT available

- No developer portal, API reference, getting-started guide, SDK, CLI, or Postman collection
- No published OpenAPI, AsyncAPI, GraphQL schema, or .proto — probed /openapi.json, /openapi.yaml, /swagger.json, /v1/openapi.json, /api-docs, /docs and /redoc on every host, all 404
- No MCP server and no A2A agent card — /.well-known/agent-card.json and /.well-known/agent.json return 404 on every host
- No webhooks, event stream, or AsyncAPI document
- No status page, SLA, changelog, or deprecation policy
- No security.txt, vulnerability disclosure programme, bug bounty, or trust centre
- No GitHub organisation and no packages on npm, PyPI, or any other registry
- No pricing page or API sign-up — the support portal login is for existing customers